111 related articles for article (PubMed ID: 157998)
1. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine.
Abrams DN; Knaus EE; Lentle BC; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):103-7. PubMed ID: 157998
[No Abstract] [Full Text] [Related]
2. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.
Abrams DN; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):97-101. PubMed ID: 478772
[No Abstract] [Full Text] [Related]
3. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--III. 2'-[82Br]-bromo-2'-deoxyuridine.
Lee YW; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):109-112. PubMed ID: 113355
[No Abstract] [Full Text] [Related]
4. Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.
Abrams DN; Lee YW; Mercer JR; Knaus EE; Wiebe LI
Br J Radiol; 1986 Mar; 59(699):263-70. PubMed ID: 2936414
[TBL] [Abstract][Full Text] [Related]
5. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
Woodman PW; Sarrif AM; Heidelberger C
Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphorolytic degradation of 5-fluoro-2'-deoxyuridine by pyrimidine acyclonucleosides and normal pyrimidine metabolites in rat and beagle tissue homogenates.
Kawaguchi T; Saneyoshi M
Chem Pharm Bull (Tokyo); 1988 May; 36(5):1899-901. PubMed ID: 2974322
[No Abstract] [Full Text] [Related]
7. The disposition of the antitumor agent, sangivamycin, in mice.
Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
[No Abstract] [Full Text] [Related]
8. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.
Lee YW; Iwashina T; Gati WP; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1985 May; 36(5):395-8. PubMed ID: 4018900
[TBL] [Abstract][Full Text] [Related]
9. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
Lokshina AM; Pelevina II
Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
[No Abstract] [Full Text] [Related]
10. [Estimation of tumor sensitivity in vitro. II. Studies with the solid Ehrlich carcinoma of the mouse and the GW 77, a heterotransplanted human carcinoma].
Seidel HJ
Z Krebsforsch; 1970; 74(2):131-40. PubMed ID: 4103128
[No Abstract] [Full Text] [Related]
11. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
12. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil.
Lee YW; Abrams DN; Wiebe LI; Knaus EE
Int J Nucl Med Biol; 1984; 11(3-4):262-6. PubMed ID: 6549392
[No Abstract] [Full Text] [Related]
13. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
14. Tumor specific conversion of a pyrimidine antimetabolite.
Hartmann HR; Bollag W
Adv Exp Med Biol; 1984; 165 Pt B():411-4. PubMed ID: 6232832
[TBL] [Abstract][Full Text] [Related]
15. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
[TBL] [Abstract][Full Text] [Related]
16. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
Fedorov NA; Matveenko VN; Tikhonova EF
Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
[No Abstract] [Full Text] [Related]
17. FLUORINATED PYRIMIDINES. XX. INHIBITION OF THE NUCLEOSIDE PHOSPHORYLASE CLEAVAGE OF 5-FLUORO-2'-DEOXYURIDINE BY 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
HEIDELBERGER C; BIRNIE GD; BOOHAR J; WENTLAND D
Biochim Biophys Acta; 1963 Oct; 76():315-8. PubMed ID: 14097389
[No Abstract] [Full Text] [Related]
18. PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. 3. RELATIONSHIP OF THYMIDINE TO THE METABOLISM OF OTHER PYRIMIDINE NUCLEOSIDES IN SUSPENSION CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA.
GENTRY GA; MORSE PA; POTTER VR
Cancer Res; 1965 May; 25():517-25. PubMed ID: 14302036
[No Abstract] [Full Text] [Related]
19. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
KRISS JP; BOND SB
Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
[No Abstract] [Full Text] [Related]
20. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VII. [2-14C]-5-ethyl-1-(2'-deoxy-beta-D-ribofuranosyl)uracil.
Lee YW; Giziewicz JB; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1984 Nov; 35(11):1063-6. PubMed ID: 6335492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
